Hydroxy-substituted azetidinone compounds useful as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reissue Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C540S200000

Reissue Patent

active

RE042461

ABSTRACT:
Hydroxy-substituted azetidinone hypocholesterolemic agents of the formulaor a pharmaceutically acceptable salt thereof, wherein:Ar1and Ar2are aryl or R4-substituted aryl;Ar3is aryl or R5-substituted aryl;X, Y and Z are —CH2—, —CH(lower alkyl)— or —C(dilower alkyl)—;R and R2are —OR6, —O(CO)R6, —O(CO)OR9or —O(CO)NR6R7;R1and R3are H or lower alkyl;q is 0 or 1; r is 0 or 1; m, n and p are 0-4; provided that at least one of q and r is 1, and the sum of m, n, p, q and r is 1-6; and provided that when p is O and r is 1, the sum of m, q and n is 1-5;R4is selected from lower alkyl, R5, —CF3, —CN, —NO2and halogen R5is selected from —OR6, —O(CO)R6, —O(CO)OR9, —O(CH2)1-5OR6, —O(CO)NR6R7, —NR6R7, —NR6(CO)R7, —NR6(CO)OR9, —NR6(CO)NR7R8, —NR6SO2R9, —COOR6, —CONR6R7, —COR6, —SO2NR6R7, S(O)0-2R9, —O(CH2)1-10—COOR6, —O(CH2)1-10CON6R7, —(lower alkylene)COOR6and —CH═CH—COOR6;R6, R7and R8are H, lower alkyl or aryl-substituted IcR9is lower alkyl, aryl or aryl-substituted lower alkyl;are disclosed, as well as a method of lowering serum cholesterol by administering said compounds, alone or in combination with a cholesterol biosynthesis inhibitor, pharmaceutical compositions containing them; and a process for preparing them.

REFERENCES:
patent: 4144232 (1979-03-01), Koppel et al.
patent: 4375475 (1983-03-01), Willard et al.
patent: 4443372 (1984-04-01), Luo et al.
patent: 4479900 (1984-10-01), Luo
patent: 4500456 (1985-02-01), Spitzer et al.
patent: 4576749 (1986-03-01), Zahler et al.
patent: 4576753 (1986-03-01), Kamiya et al.
patent: 4595532 (1986-06-01), Miller
patent: 4620867 (1986-11-01), Luo
patent: 4633017 (1986-12-01), Mueller et al.
patent: 4659716 (1987-04-01), Villani et al.
patent: 4675399 (1987-06-01), Miller
patent: 4680391 (1987-07-01), Firestone et al.
patent: 4759923 (1988-07-01), Buntin et al.
patent: 4784734 (1988-11-01), Torii et al.
patent: 4794108 (1988-12-01), Kishimoto et al.
patent: 4803266 (1989-02-01), Kawashima et al.
patent: 4806564 (1989-02-01), Chabala et al.
patent: 4816477 (1989-03-01), Girotra et al.
patent: 4834846 (1989-05-01), Abramson et al.
patent: 4847271 (1989-07-01), Chabala et al.
patent: 4876365 (1989-10-01), Kirkup et al.
patent: 4983597 (1991-01-01), Yang et al.
patent: 5030628 (1991-07-01), Joyeau et al.
patent: 5099034 (1992-03-01), Yoshida et al.
patent: 5120729 (1992-06-01), Chabala et al.
patent: 5124337 (1992-06-01), Dugar et al.
patent: 5159025 (1992-10-01), Terada
patent: 5229381 (1993-07-01), Doherty et al.
patent: 5229510 (1993-07-01), Knight et al.
patent: 5238950 (1993-08-01), Clader et al.
patent: 5306817 (1994-04-01), Thiruvengadam et al.
patent: 5348953 (1994-09-01), Doherty et al.
patent: 5350868 (1994-09-01), Yoshida et al.
patent: 5412092 (1995-05-01), Rey et al.
patent: 5550229 (1996-08-01), Iwasaki et al.
patent: 5576470 (1996-11-01), Tuller et al.
patent: 5595997 (1997-01-01), Aberg et al.
patent: 5624920 (1997-04-01), McKittrick et al.
patent: 5631365 (1997-05-01), Rosenblum et al.
patent: 5633246 (1997-05-01), McKittrick et al.
patent: 5661145 (1997-08-01), Davis
patent: 5688785 (1997-11-01), Vaccaro
patent: 5688787 (1997-11-01), Burnette et al.
patent: 5688990 (1997-11-01), Shankar
patent: 5698548 (1997-12-01), Dugar et al.
patent: 5728827 (1998-03-01), Thiruvengadam et al.
patent: 5739321 (1998-04-01), Wu et al.
patent: 5744467 (1998-04-01), McKittrick et al.
patent: 5767115 (1998-06-01), Rosenblum et al.
patent: 5767126 (1998-06-01), Marchbanks
patent: 5817806 (1998-10-01), Rossi et al.
patent: 5846966 (1998-12-01), Rosenblum et al.
patent: 5847115 (1998-12-01), Iwasaki et al.
patent: 5856473 (1999-01-01), Shankar
patent: 5925668 (1999-07-01), Biewenga et al.
patent: RE36481 (2000-01-01), Inamine et al.
patent: 6372756 (2002-04-01), Christians et al.
patent: 6455572 (2002-09-01), Day et al.
patent: 6465490 (2002-10-01), Bernotas et al.
patent: 6982251 (2006-01-01), Ghosal et al.
patent: 1063108 (1979-09-01), None
patent: 1173837 (1984-09-01), None
patent: 1213596 (1986-11-01), None
patent: 1253146 (1989-04-01), None
patent: 1262357 (1989-10-01), None
patent: 1267415 (1990-04-01), None
patent: 1268780 (1990-05-01), None
patent: 2004355 (1990-06-01), None
patent: 2024267 (1991-03-01), None
patent: 1286304 (1991-07-01), None
patent: 2052973 (1992-04-01), None
patent: 2072215 (1992-12-01), None
patent: 2114007 (1993-02-01), None
patent: 2152351 (1994-07-01), None
patent: 1331755 (1994-08-01), None
patent: 2154257 (1994-08-01), None
patent: 2172149 (2000-11-01), None
patent: 2046823 (1972-03-01), None
patent: 0 199 630 (1986-10-01), None
patent: 0199630 (1986-10-01), None
patent: 0 264 231 (1988-04-01), None
patent: 0264231 (1988-04-01), None
patent: 0 333 268 (1989-09-01), None
patent: 0333268 (1989-09-01), None
patent: 0337 549 (1989-10-01), None
patent: 0337549 (1989-10-01), None
patent: 0 365 364 (1990-04-01), None
patent: 0365364 (1990-04-01), None
patent: 0 401 705 (1990-12-01), None
patent: 0 415 487 (1991-03-01), None
patent: 0415487 (1991-03-01), None
patent: 0 462 667 (1991-12-01), None
patent: 0462667 (1991-12-01), None
patent: 0 481 671 (1992-04-01), None
patent: 0481671 (1992-04-01), None
patent: 508 425 (1992-10-01), None
patent: 0 524 595 (1993-01-01), None
patent: 524 595 (1993-01-01), None
patent: 0524595 (1993-01-01), None
patent: 0720599 (1996-07-01), None
patent: 8-505141 (1996-04-01), None
patent: WO87/04429 (1987-07-01), None
patent: WO93/02048 (1993-02-01), None
patent: WO 94/06784 (1994-03-01), None
patent: WO94/17038 (1994-04-01), None
patent: WO94/14433 (1994-07-01), None
patent: WO94/17036 (1994-08-01), None
patent: WO94/17038 (1994-08-01), None
patent: WO 94/19351 (1994-09-01), None
patent: WO95/08532 (1995-03-01), None
patent: WO01/32161 (2001-05-01), None
Allain et al., Enzymatic Determination of Total Serum Cholesterol, Clinical Chemical 20:470-475 (1974).
Baxter, Squalestatin 1, a Potent Inhibitor of Squalene Synthase, Which Lowers Serum Cholesterol in vivo, Journal of Biological Chemistry 267:11705-11708 (1992).
Burrier et al., The Effect of Acyl CoA:Cholesterol Acyltransferase Inhibition on the Uptake, Esterification and Secretion of Cholesterol by the Hamster Small Intestine, The Journal of Pharmacology and Experimental Therapeutics 272:156-163 (1994).
Burrier et al., Demonstration of a Direct Effect on Hepatic Acyl CoA:Cholesterol Acyl Transferase (ACAT) Activity By An Orally Administered Enzyme Inhibitor in the Hamster, Biochemical Pharmacology 47:1545-1551 (1994).
Clader et al., Substituted (1,2-Diarylethyl)amide Acy-CoA:Cholesterol Acyltransferase Inhibitors: Effect of Polar Groups in Vitro and in Vivo Activity, Journal of Medicinal Chemistry 38:1600-1607 (1995).
Durst et al., Metallation of N-Substituted β-Lactams, A Method for the Introduction of 3-Substituents into β-Lactams, Canadian Journal of Chemistry, 50:3196-3201 (1971).
Georg et al., 3-(1′-Hydroxyethyl)-2-Azetidinones From 3-Hydroxybutyrates and N-Arylaldimines, Tetrahedron Letters 26(33):3903-3906 (1985).
Hart et al., An Enantioselective Approach to Carbapenen Antibodies: Formal Synthesis of (+)-Thienamycin, Tetrahedron Letters, 26(45):5493-5496 (1985).
Harwood, Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin β-tigogenin cellobioside (CP-88818; liqueside), Journal of Lipid Research 34:377-395 (1993).
Hoekman et al., Synthesis of Homologues of 4,5-Dihydroxy- and 4-Hydroxy-5-oxohexanoic Add δ-Lactones, J. Agric, Food Chem. 30:920-924 (1982).
Horie et al., Hypolipidemic effects of NB-598 in dogs, Atherosclerosis 88:183-192 (1991).
Illingworth, An Overview of Lipid-Lower Drugs, Drugs 36:63:71 (1988).
International Search Report dated Dec. 8, 1994 in PCT/US94/10099.
Mayrhofer et al., Simple Prep. of 3-Benzylidene-2-azetilidinones, Synthesis 2

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hydroxy-substituted azetidinone compounds useful as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydroxy-substituted azetidinone compounds useful as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxy-substituted azetidinone compounds useful as... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2673623

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.